Position in TLRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$729,317
-$329,522 QoQ
Shares Held
112,723
-3.9% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Cresset Asset Management, LLC holds $16,229,662 across 10 Drug Manufacturers - Specialty & Generic names. TLRY ranks #4 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
88,702 | $10,485,463 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,332 | $2,568,789 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
10,572 | $801,886 | |
| 4 | TLRY |
Tilray Brands, Inc.
This page
|
112,723 | $729,317 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
74,814 | $712,229 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
17,304 | $414,084 | |
| 7 | SIGA |
Siga Technologies Inc
|
40,690 | $217,691 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,954 | $209,454 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $729,317 | 112,723 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,058,839 | 117,258 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||